Robert Camerlinck - 01 Aug 2022 Form 3 Insider Report for Cano Health, Inc.

Role
Chief Operating Officer
Signature
/s/ David J. Armstrong, attorney-in-fact
Issuer symbol
N/A
Transactions as of
01 Aug 2022
Net transactions value
$0
Form type
3
Filing time
12 Aug 2022, 19:36:09 UTC
Next filing
12 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CANO Class A Common Stock 23,235,667 01 Aug 2022 Direct F1
holding CANO Class A Common Stock 285,333 01 Aug 2022 Direct F2
holding CANO Class A Common Stock 39,523 01 Aug 2022 Direct F3
holding CANO Class A Common Stock 7,214 01 Aug 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CANO Stock Option (Right to Buy) 01 Aug 2022 Class A Common Stock 150,174 $14.75 Direct F4
holding CANO Stock Option (Right to Buy) 01 Aug 2022 Class A Common Stock 150,174 $14.75 Direct F4
holding CANO Stock Option (Right to Buy) 01 Aug 2022 Class A Common Stock 150,174 $14.75 Direct F4
holding CANO Stock Option (Right to Buy) 01 Aug 2022 Class A Common Stock 150,178 $14.75 Direct F4
holding CANO Stock Option (Right to Buy) 01 Aug 2022 Class A Common Stock 11,546 $6.03 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 2,857,092 shares of Class A common stock are subject to a lock-up that expires on January 2023.
F2 These shares represent restricted stock units ("RSUs") granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan. Each unit represents a right to receive one share of the Issuer's Class A Common Stock. The RSUs will vest over four years, with 25% of the shares underlying the award vesting on August 24, 2022, and 25% of the shares underlying the award vesting at the end of each successive one-year period thereafter. The RSUs were granted on March 15, 2022.
F3 These shares represent RSUs granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan. Each unit represents a right to receive one share of the Issuer's Class A Common Stock. The RSUs will vest as to 50% of the RSUs on December 31, 2022 and the remaining 50% of the RSUs will vest on December, 31, 2023. The RSUs were granted on March 15, 2022.
F4 The stock option is granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan and is scheduled to vest over two years, with 50% of the shares underlying the award vesting on June 3, 2024 and the remaining 50% of the shares underlying the award vesting on June 3, 2025. The stock option was granted on June 3, 2021.
F5 The stock option is granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan and is scheduled to vest over four years, with 25% of the shares underlying the award vesting on March 15, 2023, and 25% of the shares underlying the award vesting at the end of each successive one-year period thereafter. The stock option was granted on March 15, 2022.

Remarks:

Exhibit 24 - Power of Attorney